Biosimilar characterization – scientific resources

Share on linkedin
Share on twitter
Share on facebook
Some interesting scientific resources on biosimilar characterization

Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

Authors: Ali M. Alsamil, Thijs J. Giezen, Toine C. Egberts, Hubert G. Leufkens, Arnold G. Vulto, Martijn R. van der Plas &  Helga Gardarsdottir
“Biosimilars are not identical like generics, but highly similar versions where demonstrating biosimilarity of quality attributes (QAs) to a reference product is the basis of development and regulatory approval. Information on QAs assessed to establish biosimilarity may not always be publicly available, although this information is imperative to understand better the science behind biosimilars approval. This study aims to identify QA types reported in publications presenting biosimilarity assessments of (intended) biosimilars over time”….to read the full article click here

Evidentic as company can provide you therapeutic antibodies during the early development stage. Some popular choices from our list of therapeutic antibodies are:

Avelumab – Drug Aliquots

Bevacizumab – Drug Aliquots

Cetuximab – Drug Aliquots

See the full list of therapeutic antibodies and get them delivered in less than 7 days.

Publishing Date:
Friday, 18 September, 2020


About Evidentic

Evidentic is a young innovative company providing original drugs for research and new drug development.
Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.

Follow Us

Introduction to Evidentic


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video


By loading the post, you agree to Facebook's privacy policy.
Learn more

Load post

Read more

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.